Durvalumab vs Pentamidine Isethionate

## Durvalumab vs Pentamidine Isethionate: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Pentamidine Isethionate**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Pentamidine Isethionate — N/A.

## Chemical Properties

**Type**: Durvalumab — Antibody; Pentamidine Isethionate — Small molecule.